From Liver Damage, Patient Deaths Lead FDA to Halt SeaGen Leukemia Trials:

acute myeloid leukemia (AML)

acute myeloid leukemia (AML)—

Human cells with acute myeloid leukemia, image from the National Cancer Institute:

https://visualsonline.cancer.gov/details.cfm?imageid=2336

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Bridging the Diversity Gap with Decentralized Trials
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
PRA Health Sciences

Sponsored · Whitepaper
IBM Watson Health Data in Action – Epidemiology Studies
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Xconomy on Demand

We offer a number of ways to subscribe for free!